Stay updated with breaking news from 45337c10. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com upgraded shares of Incyte (NASDAQ:INCY – Get Rating) from a buy rating to a strong-buy rating in a research note released on Monday morning. A number of other brokerages have also recently weighed in on INCY. William Blair restated an outperform rating on shares of Incyte in a research note on Monday, March 20th. […]
Los Angeles Capital Management LLC increased its stake in Incyte Co. (NASDAQ:INCY – Get Rating) by 24.4% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 632,192 shares of the biopharmaceutical company’s stock after purchasing an additional 124,005 shares during the quarter. Los […]
Incyte (NASDAQ:INCY – Get Rating) was upgraded by StockNews.com from a “buy” rating to a “strong-buy” rating in a report issued on Monday. Several other research firms have also recently weighed in on INCY. Cowen raised their price objective on shares of Incyte from $95.00 to $100.00 and gave the company an “outperform” rating in […]
Incyte Co. (NASDAQ:INCY – Get Rating) was the recipient of a significant increase in short interest in March. As of March 31st, there was short interest totalling 8,240,000 shares, an increase of 26.2% from the March 15th total of 6,530,000 shares. Based on an average trading volume of 1,590,000 shares, the short-interest ratio is currently […]
180 Wealth Advisors LLC grew its stake in Incyte Co. (NASDAQ:INCY – Get Rating) by 4.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,613 shares of the biopharmaceutical company’s stock after purchasing an additional 139 shares during the quarter. 180 […]